"In 2012, we decided to open a representative office in Indonesia because of the high dynamism of the national regulatory environment as well as our corporate…
In Conversation
"Our innovative cancer medicine gives physicians a new therapeutic option and hope in managing the tens of thousands of lung cancer patients across the country."
"In order to succeed, pharmaceutical players have to introduce medicines that fulfill the local healthcare needs and create healthcare breakthroughs in Indonesia"
"Indonesia must deliver aggressive growth for our regional business. Anything less than 15 percent would be below our expectations. "
"The strategy has been very clear since the foundation of the company. We are looking for unmet needs in the market that we can fully satisfy…
"Boehringer Ingelheim has been one of the fastest-growing players within the top 20 pharmaceutical companies in Indonesia for the past two years."
"The USA contributes about USD 90 billion a year to Indonesia’s GDP, or roughly 10 percent. This really highlights that America’s private sector is one of the…
"Our country is made up of 60 percent water and 40 percent land and we have more than a thousand islands. With such a geographical structure,…
"We are continuously dealing with the private industry and we obviously check that all companies that are working with us are fully complying with the national…
"Thus, the national health insurance has been intensively evolving since its creation and different stakeholders have been involved in the transformation to ensure a proper evolution."
"In terms of international collaboration, we are receiving help from Japan and we already send some of our researchers to this country in order to study…
"Being able to adapt our operations according to latest industry trends has been one of the main factors behind our success in the country during the…
